Header Logo

Connection

RACHEL SCHIFF to Receptors, Somatotropin

Back to Details
This is a "connection" page, showing publications RACHEL SCHIFF has written about Receptors, Somatotropin.
RACHEL SCHIFF
Connection Strength
0.067
Receptors, Somatotropin
  1. The growth hormone receptor antagonist pegvisomant blocks both mammary gland development and MCF-7 breast cancer xenograft growth. Breast Cancer Res Treat. 2006 Aug; 98(3):315-27.
    View in: PubMed
    Score: 0.067
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.